Navigation Links
Gentiva® Health Services Schedules 2011 Outlook Conference Call and Webcast for Thursday, December 16, 2010
Date:12/3/2010

ts of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters, pandemic outbreaks, or terrorist acts; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended January 3, 2010, as supplemented in the Company's quarterly report on Form 10-Q for the second quarter ended July 4, 2010.Financial and Investor Contact:
Eric Slusser 770-951-6101eric.slusser@gentiva.comor John Mongelli770-221-6700john.mongelli@gentiva.comMedia Contact:Scott CianciulliBrainerd Communicators212-986-6667cianciulli@braincomm.com
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Crescent Healthcare Expands East Coast Presence
2. HeartWare to Present at the 22nd Annual Piper Jaffray Health Care Conference
3. Ridge Diagnostics, Inc. Presents Clinical Data on Blood Test for Depression at U.S. Psychiatric and Mental Health Congress
4. Chimerix Presents Update on CMX001 Development to the World Health Organization Advisory Committee on Variola Virus Research
5. The Israeli Governments Ministry of Health Invites Medisafe 1 Technologies to Demonstrate its Unique Syringe Locking Device Technology
6. Keryx Biopharmaceuticals to Present at Lazard Capital Markets 7th Annual Healthcare Conference
7. Intarcia Therapeutics Executive Chairman, Kurt Graves to Present at Lazard Capital Markets 7th Annual Healthcare Conference
8. Argos Therapeutics to Present Corporate Overview and Next Steps in Clinical Development of Arcelis™ Immunotherapy at Lazard Capital Markets 7th Annual Healthcare Conference
9. Accuray Incorporated to Speak at Seventh Annual Lazard Capital Markets Healthcare Conference
10. Anadys Pharmaceuticals to Present at the Lazard Healthcare Conference
11. Marshall Edwards CEO to Present at Lazard Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 Genedata, a leading ... and life science research, today announced that Pfizer ... platform for use at Pfizer biopharma research and ... is supporting Pfizer’s global deployment and roll out ... for Therapeutic Innovation (CTI), and Pharmaceutical Sciences groups. ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Personalized Medicine ... offering. , The aim of ... the right drug to the right patient and, ... treatment for a patient according to his/her genotype. ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Gene Therapy - ... , Gene therapy technologies are ... and cell therapy with genetically modified vectors. Gene ... and various routes of administration as well as ...
(Date:3/3/2015)... -- Elsevier,s DirectCourse online curricula provides ... to comply with new CMS requirements   ... new crosswalk tool to help providers of Home ... service workers as a means to comply with new ... CMS amended the regulations, effective March 17, 2015, ...
Breaking Biology Technology:Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 3
... Nov. 20 ,Exelixis, Inc. (Nasdaq: EXEL ) ... with Taconic Farms, Inc. (Hudson, NY) pursuant to ... subsidiary Artemis Pharmaceuticals GmbH,for approximately $20 million, subject ... the research, development and commercialization of,genetically engineered mouse ...
... 20 Sports and,nutritional product manufacturer, Natural Nutrition ... today that it has,launched an international marketing campaign ... Cream. Made from a combination of,botanical and organic ... internet and television. Natural Nutrition,s BLUE LIGHTNING(TM) ...
... Technology, ... Services to Provista, ... first awarded supplier of medical transcription technology and services,by Provista, ... agreement, Spheris will provide Provista customers with,a full range of ...
Cached Biology Technology:Exelixis Sells 80% Stake in Artemis to Taconic 2Exelixis Sells 80% Stake in Artemis to Taconic 3Exelixis Sells 80% Stake in Artemis to Taconic 4Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief 2Provista Awards Agreement to Spheris 2
(Date:2/10/2015)... WALTHAM, Mass., Feb. 10, 2015  Alere Inc. ... announced its financial results for the quarter ended ... Executive Officer and President of Alere said, "We ... refocussing Alere as the global leader in rapid ... closing the Alere Health divestiture in early January ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 26, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... a new corporate website ( http://www.nxt-id.com/ ) as part ... Wocket™ smart wallet. The Company launched its new consumer ... Gino Pereira , CEO of NXT-ID said, "Our ...
(Date:2/5/2015)... 2015  It is gratifying to see that the ... genomic science as a means to better understand human ... I was honored to participate in today,s White House ... Since the 1980s my teams have ... first sequenced genome of a free living organism, the ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... FASEB MARC (Minority Access to Research Careers) Program has ... 98th Annual Meeting of The American Association of Immunologists ... May 13-17, 2011. These awards are meant to ... scientists into the mainstream of the basic science community ...
... to climate warming in alpine regions is putting pressure on ... study recently released in Climatic Change Letters . ... the University of Montana, U.S. Fish and Wildlife Service and ... good early warning indicators of climate warming in mountain ecosystems. ...
... Ennova Direct, Inc. (DBA ION Technologies) announced today that ... that is focused on Retractable USB Flash Drive Devices, ... and Wireless Bluetooth™) and Wireless Bluetooth Earbud Headsets. In ... US patents (US 6,979,210, US 7,040,425, US 7,090,515, US ...
Cached Biology News:MARC travel awards announced for Immunology 2011 2MARC travel awards announced for Immunology 2011 3Ennova Direct Announces the Sale of its Consumer Electronics/Computer Peripheral Patent Portfolio 2
Assay Diluent 500 mls...
Quinolinate phosphoribosyltransferase...
ICC Diluent Buffer 250 ml...
This antibody is specific for human J-chain as defined by ELISA assay using purified human immunoglobulin fragments as solid phase target antigen....
Biology Products: